AGTR1 and myocardial infarction: SNT improves cardiac function by inhibiting the excessive activation of the renin-angiotensin-aldosterone system, which involves a reduction in the levels of plasma angiotensin II and downregulation of the protein and gene levels of AT1R in heart failure after myocardial infarction in rats [41].